Perks and pitfalls of pursuing broad biotech platform patents using functional language
21 January 2026
Drawing on recent EPO and UPC proceedings, including Amgen v Sanofi & Regeneron (EP 3 666 797), our experts will examine the implications of key decisions for the prosecution and defence of broad functional claims.